Brief: Rvl Pharmaceuticals PLC Announces Insider And Athyrium-Led Financing
04/08/2022 22:47
Aug 4 (Reuters) - RVL Pharmaceuticals PLC RVLP.O :
* RVL PHARMACEUTICALS PLC ANNOUNCES INSIDER AND ATHYRIUM-LED
FINANCING
* RVL PHARMA- CASH RUNWAY TO EXTEND THROUGH 2023 WITH $43.9
MILLION FUNDED AT CLOSING AND AN ADDITIONAL $25.0 MILLION OF
AVAILABILITY THROUGH APRIL 2023
* RVL PHARMACEUTICALS PLC - SECURED $68.9 MILLION IN
COMMITTED
FINANCING THROUGH A COMBINATION OF EQUITY AND NON-DILUTIVE DEBT
FINANCING
Source text for Eikon: ID:nGNX5gRVf2
Further company coverage: RVLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius